MINNEAPOLIS--(BUSINESS WIRE)--Medtronic, Inc. (NYSE:MDT) today announced a registered offering of $675 million of its 3.125% Senior Notes due 2022 and $400 million of its 4.50% Senior Notes due 2042 (collectively, the “Notes”). Medtronic intends to use the net proceeds for working capital and general corporate purposes, which may include repayment of its indebtedness.
